Iovance Biotherapeutics Inc (IOVA)
8.45
+0.30
(+3.62%)
USD |
NASDAQ |
Jun 25, 16:00
8.41
-0.04
(-0.47%)
After-Hours: 20:00
Iovance Biotherapeutics Free Cash Flow: -405.08M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -405.08M |
| December 31, 2023 | -384.11M |
| September 30, 2023 | -377.30M |
| June 30, 2023 | -354.68M |
| March 31, 2023 | -333.42M |
| December 31, 2022 | -313.18M |
| September 30, 2022 | -293.91M |
| June 30, 2022 | -296.25M |
| March 31, 2022 | -277.66M |
| December 31, 2021 | -265.52M |
| September 30, 2021 | -290.12M |
| June 30, 2021 | -281.11M |
| March 31, 2021 | -259.09M |
| December 31, 2020 | -251.92M |
| September 30, 2020 | -223.15M |
| June 30, 2020 | -208.20M |
| March 31, 2020 | -201.82M |
| December 31, 2019 | -165.81M |
| September 30, 2019 | -140.40M |
| June 30, 2019 | -125.38M |
| March 31, 2019 | -114.49M |
| December 31, 2018 | -102.45M |
| September 30, 2018 | -91.51M |
| June 30, 2018 | -84.83M |
| March 31, 2018 | -78.01M |
| Date | Value |
|---|---|
| December 31, 2017 | -79.74M |
| September 30, 2017 | -71.73M |
| June 30, 2017 | -62.96M |
| March 31, 2017 | -49.24M |
| December 31, 2016 | -34.19M |
| September 30, 2016 | -28.02M |
| June 30, 2016 | -19.00M |
| March 31, 2016 | -19.84M |
| December 31, 2015 | -19.52M |
| September 30, 2015 | -17.53M |
| June 30, 2015 | -15.51M |
| March 31, 2015 | -12.20M |
| December 31, 2014 | -10.22M |
| September 30, 2014 | -7.737M |
| June 30, 2014 | -6.287M |
| March 31, 2014 | -5.645M |
| December 31, 2013 | -3.674M |
| September 30, 2013 | -1.422M |
| June 30, 2013 | -1.263M |
| March 31, 2013 | -1.781M |
| December 31, 2012 | -2.242M |
| September 30, 2012 | -4.962M |
| June 30, 2012 | -6.334M |
| March 31, 2012 | -6.416M |
| December 31, 2011 | -6.220M |
Free Cash Flow Range, Past 5 Years
-405.08M
Minimum
Mar 2024
-125.38M
Maximum
Jun 2019
-272.41M
Average
-279.38M
Median
Free Cash Flow Benchmarks
| Viatris Inc | 2.000B |
| Beam Therapeutics Inc | -169.28M |
| Revolution Medicines Inc | -457.88M |
| Day One Biopharmaceuticals Inc | -170.60M |
| Viking Therapeutics Inc | -54.87M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -122.28M |
| Cash from Investing (Quarterly) | -111.51M |
| Cash from Financing (Quarterly) | 193.58M |
| Free Cash Flow Per Share (Quarterly) | -0.475 |
| Free Cash Flow to Equity (Quarterly) | -126.45M |
| Free Cash Flow to Firm (Quarterly) | -126.45M |
| Free Cash Flow Yield | -19.32% |